THM Capital Advisory advises Alicante in the sale of CotOptim software to 123CS

THM Capital Advisory advised Alicante on the sale of the CotOptim software to 123CS, a company specializing in the computer security of information systems and the provision of IT solutions for health professionals.

Since September 2023, 123CS — until now a subsidiary of the Verso Healthcare Group within MACSF — has been taken over by the founder of Verso Healthcare.

Alicante has been a pioneer company for 25 years in the development of expertise in artificial intelligence, focused on semantic analysis search engines and dedicated to health.

Since 2018, the publisher has been developing a software suite allowing public and private MCO and SMR health institutions to optimize, automate and perform quality control on their PMSI coding.

In this context, Alicante has applied its expertise by developing CotOptim, an AI software that lists the comprehensiveness of medical procedures performed and the quality of their coding in order to optimize the revenues of radiology practices.

Dedicated to private radiological practices and to the radiology departments of hospitals and clinics, CotOptim also aims to improve the quality control of billing, to reduce billing rejections and to limit the time spent on these tasks by medical and administrative teams.

This operation responds to a logic of strategic focus: Alicante has decided to sell CotOptim in order to focus on its core customers — MCO and SMR hospitals and clinics — while 123CS strengthens its range of products and services and intends to accelerate the commercial development of CotOptim among radiologists.

THM Capital Advisory advised Alicante as financial advisor (Thomas Mitard, Aurélien Prost), and Skills Avocats (Plamenka Kuna Renard) acted as legal advisor to the purchaser.